Hypercalcemia and cancer: Differential diagnosis and treatment
- PMID: 30240520
- DOI: 10.3322/caac.21489
Hypercalcemia and cancer: Differential diagnosis and treatment
Abstract
Incidentally detected hypercalcemia usually presents in an indolent manner and is most likely caused by primary hyperparathyroidism. In contrast, hypercalcemia in the patient with a history of cancer presents in a wide range of clinical settings and may be severe enough to warrant hospitalization. This form of hypercalcemia is usually secondary to hypercalcemia of malignancy and can be fatal. Hypercalcemia of malignancy is most commonly mediated by tumoral production of parathyroid hormone-related protein or by cytokines activating osteoclast degradation of bone. The initial workup, differential diagnoses, confirmatory laboratory testing, imaging, and medical and surgical management of hypercalcemia are described in the patient with cancer.
Keywords: evaluation; malignancy; management; paraneoplastic syndrome.
© 2018 American Cancer Society.
Similar articles
-
Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with clear cell endometrial cancer.South Med J. 2008 Dec;101(12):1266-8. doi: 10.1097/SMJ.0b013e318181d59d. South Med J. 2008. PMID: 19005452
-
How to approach hypercalcaemia.Clin Med (Lond). 2013 Jun;13(3):287-90. doi: 10.7861/clinmedicine.13-3-287. Clin Med (Lond). 2013. PMID: 23760705 Free PMC article.
-
Humoral Hypercalcemia in Uterine Cancers: A Case Report and Literature Review.Am J Case Rep. 2017 Jan 6;18:22-25. doi: 10.12659/ajcr.900088. Am J Case Rep. 2017. PMID: 28057913 Free PMC article. Review.
-
Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1.Pancreas. 2011 May;40(4):634-7. doi: 10.1097/MPA.0b013e318214f65e. Pancreas. 2011. PMID: 21483254
-
Primary hyperparathyroidism and parathyroid hormone-related protein.Curr Opin Rheumatol. 1994 May;6(3):321-8. doi: 10.1097/00002281-199405000-00014. Curr Opin Rheumatol. 1994. PMID: 8060769 Review.
Cited by
-
Bone targeted nano-drug and nano-delivery.Bone Res. 2024 Sep 4;12(1):51. doi: 10.1038/s41413-024-00356-2. Bone Res. 2024. PMID: 39231955 Free PMC article. Review.
-
Hypercalcemia in Cancer: Causes, Effects, and Treatment Strategies.Cells. 2024 Jun 18;13(12):1051. doi: 10.3390/cells13121051. Cells. 2024. PMID: 38920679 Free PMC article. Review.
-
Identification of allograft inflammatory factor-1 suppressing the progression and indicating good prognosis of osteosarcoma.BMC Musculoskelet Disord. 2024 Mar 23;25(1):233. doi: 10.1186/s12891-024-07363-8. BMC Musculoskelet Disord. 2024. PMID: 38521928 Free PMC article.
-
Hypercalcaemia of malignancy: a case of vitamin-D-mediated hypercalcaemia in lymphoma.BMJ Case Rep. 2024 Feb 6;17(2):e256126. doi: 10.1136/bcr-2023-256126. BMJ Case Rep. 2024. PMID: 38320825
-
Giant Mandibular Ameloblastoma with Rare Hypercalcemia: A Case Report and Literature Review.Medicina (Kaunas). 2023 Nov 6;59(11):1956. doi: 10.3390/medicina59111956. Medicina (Kaunas). 2023. PMID: 38004005 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
